2023
DOI: 10.1101/2023.09.13.557571
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Resolving the nanoscale structure of β-sheet assemblies using single-molecule orientation-localization microscopy

Weiyan Zhou,
Conor L. O’Neill,
Tianben Ding
et al.

Abstract: Synthetic peptides that self-assemble into cross-β fibrils have remarkable utility as engineered biomaterials due to their modularity and biocompatibility, but their structural and morphological similarity to amyloid species has been a long-standing concern for their translation. Further, their polymorphs are difficult to characterize using spectroscopic and imaging techniques that rely on ensemble averaging to achieve high resolution. Here, we utilize single-molecule orientation-localization microscopy (SMOLM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 79 publications
0
1
0
Order By: Relevance
“…Through careful analysis of the SMOLM data, structural polymorphisms in the β-sheet assemblies may be resolvable. 38 Beyond our proof-of-principle experiments, different Aβ42 seedings can be utilized to prepare and analyze a selection of pathologically relevant Aβ42 structures, thereby enabling the study of how different preparations affect structural dynamics. More broadly, future studies can also target other amyloid peptides implicated in neurodegeneration, such as Aβ40.…”
mentioning
confidence: 99%
“…Through careful analysis of the SMOLM data, structural polymorphisms in the β-sheet assemblies may be resolvable. 38 Beyond our proof-of-principle experiments, different Aβ42 seedings can be utilized to prepare and analyze a selection of pathologically relevant Aβ42 structures, thereby enabling the study of how different preparations affect structural dynamics. More broadly, future studies can also target other amyloid peptides implicated in neurodegeneration, such as Aβ40.…”
mentioning
confidence: 99%